On October 31, the U.S. District Court for the Eastern District of Virginia granted a preliminary injunction blocking the U.S. Patent Office’s Claims and Continuations Rules from taking effect. While the rules are on hold, nutraceutical companies need to remain informed so they can make decisions that will maximize the value of their patent portfolios during these uncertain times. In her byline on www.nutraingredients-usa.com, Foley’s Courtenay Brinckerhoff highlights some of the arguments by Smithkline Beecham Corporation (GSK), who challenged the court on the rules, as well as the court’s decisions and the possible impact on nutraceutical companies
Click here for the full article.
Author(s)
Related Insights
June 20, 2025
Foley Career Perspectives
Foley Juneteenth Program: Exploring the Hidden History to Further Our Mutual Understanding
In celebration of Juneteenth, Foley & Lardner welcomed Dr. Deirdre Cooper Owens, author and historian, for a firmwide virtual program on…
July 10, 2025
Events
Mandatory Roth Catch-up
Join Foley’s upcoming webinar on mandatory Roth catch-up contributions effective January 1, 2026. Learn how the new rules impact high earners, what guidance exists, and practical tips for plan compliance.
June 20, 2025
Foley Viewpoints
Federal Court Enjoins Former Franchisees and Two Related Entities from Competing Against Franchisor
A federal court recently granted in part and denied in part a franchisor’s motion to enjoin the post-termination activities of its former…